Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Atopic Dermatitis Topic Center

Featured

Atopic dermatitis
FDA Alerts
07/09/2024
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug...
07/09/2024
The Dermatologist
psoriasis
News
06/24/2024
Riya Gandhi, MA, Associate Editor
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical...
06/24/2024
The Dermatologist
eczema
News
06/22/2024
Riya Gandhi, MA, Associate Editor
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess long-term treatment outcomes for atopic dermatitis (AD), researchers have introduced a novel efficacy index that accounts for both on-drug and off-drug responses at Week 52.
In a new approach to assess...
06/22/2024
The Dermatologist
Atopic dermatitis
News
06/21/2024
Riya Gandhi, MA, Associate Editor
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the...
06/21/2024
The Dermatologist
Atopic dermatitis
News
06/20/2024
Jessica Garlewicz, Digital Managing Editor
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD)...
06/20/2024
The Dermatologist
AD
News
06/19/2024
Jessica Garlewicz, Digital Managing Editor
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at...
06/19/2024
The Dermatologist
social media
News
06/16/2024
Riya Gandhi, MA, Associate Editor
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the...
06/16/2024
The Dermatologist
AD
News
06/15/2024
Riya Gandhi, MA, Associate Editor
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in...
06/15/2024
The Dermatologist
AD
FDA Alerts
06/15/2024
Riya Gandhi, MA, Associate Editor
The US Food and Drug Administration has approved a new Adbry (tralokinumab-ldrm) 300 mg single-dose autoinjector, offering a new administration option for adult patients with moderate-to-severe atopic dermatitis.
The US Food and Drug Administration has approved a new Adbry (tralokinumab-ldrm) 300 mg single-dose autoinjector, offering a new administration option for adult patients with moderate-to-severe atopic dermatitis.
The US Food and Drug...
06/15/2024
The Dermatologist
medical bill
News
06/14/2024
Riya Gandhi, MA, Associate Editor
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the,...
06/14/2024
The Dermatologist
AD
News
06/13/2024
Riya Gandhi, MA, Associate Editor
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on...
06/13/2024
The Dermatologist

Multimedia

Fall Clinical AD Roundtable
Videos
11/03/2022
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs...
11/03/2022
The Dermatologist
Roundtable AAD
Videos
08/15/2022
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022...
08/15/2022
The Dermatologist
Drs Friedman, Lio, Shi and Kirkorian
Videos
07/15/2022
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs...
07/15/2022
The Dermatologist
Jeff Yu, MD
Videos
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Shawn Kwatra, MD
Videos
04/13/2022
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual...
04/13/2022
The Dermatologist
Dr Adam Friedman
Podcasts
06/21/2024
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
06/21/2024
The Dermatologist
Ramone F. Williams, MD, MPhil
Videos
06/14/2024

Featuring Ramone F. Williams, MD, MPhil

Featuring Ramone F. Williams, MD, MPh...
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F....
06/14/2024
The Dermatologist
SPONSORED VIDEO
05/22/2024
In collaboration with Regeneron’s Let’s Get Real About Skin Cancer program, a panel of distinguished dermatologists and oncologists delve into the critical importance of a multidisciplinary care team (MDT) for advanced cases of non-melanoma...
In collaboration with Regeneron’s Let’s Get Real About Skin Cancer program, a panel of distinguished dermatologists and oncologists delve into the critical importance of a multidisciplinary care team (MDT) for advanced cases of non-melanoma...
In collaboration with...
05/22/2024
The Dermatologist
The ElderDerm: Episode 3, Shared- Decision Making
Podcasts
05/16/2024

Featuring Dr Adam Friedman and Jaya Manjunath

Featuring Dr Adam Friedman and Jaya M...
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision-making is, and why it is important in dermatology.
In our next segment of the...
05/16/2024
The Dermatologist
Dr Patel
Videos
05/07/2024

Featuring Dr Vishal A. Patel, MD, FAAD, FACMS

Featuring Dr Vishal A. Patel, MD, FAA...
In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.
In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.
In this interview, Dr Vishal...
05/07/2024
The Dermatologist
Nicholas Golda, MD, FAAD, FACMS
Podcasts
05/02/2024

Featuring Nicholas Golda, MD, FAAD, FACMS

Featuring Nicholas Golda, MD, FAAD, F...
In this interview, Dr Nicholas J. Golda shares practical tips and updates on perioperative management in dermatologic surgery, covering recent advancements, common challenges, effective techniques, and emerging trends.
In this interview, Dr Nicholas J. Golda shares practical tips and updates on perioperative management in dermatologic surgery, covering recent advancements, common challenges, effective techniques, and emerging trends.
In this interview, Dr Nicholas...
05/02/2024
The Dermatologist
Dr Peter Lio
Videos
04/24/2024

Featuring Dr Peter Lio

Featuring Dr Peter Lio
In this feature Dermatology Week video, Dr Peter Lio discusses what his session, "Alternative and Complementary Dermatology: Educating Patients," will cover during the meeting.
In this feature Dermatology Week video, Dr Peter Lio discusses what his session, "Alternative and Complementary Dermatology: Educating Patients," will cover during the meeting.
In this feature Dermatology Week...
04/24/2024
The Dermatologist
Aging and Geriatric Evaluation in Dermatology
Podcasts
04/22/2024

Featuring co-hosts Dr Adam Friedman and Jaya Manjunath

Featuring co-hosts Dr Adam Friedman a...
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm Podcast, co-hosts Dr Adam Friedman and Jaya Manjunath discuss the Aging and Geriatric Evaluation in Dermatology (AGED) workgroup.
In this episode of the ElderDerm...
04/22/2024
The Dermatologist
Saakshi-Khattri
Videos
04/16/2024

Featuring Saakshi Khattri, MD

Featuring Saakshi Khattri, MD
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing on the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
Explore Dr Khattri's take on the complexities in diagnosing and treating psoriasis and psoriatic arthritis, emphasizing on the need for collaborative decision-making between dermatologists and rheumatologists for optimal patient outcomes.
Explore Dr Khattri's take on the...
04/16/2024
The Dermatologist
Lawrence F. Eichenfield, MD, FAAD
Videos
04/04/2024

Featuring Lawrence F. Eichenfield, MD, FAAD

Featuring Lawrence F. Eichenfield, MD...
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
In this interview, Dr...
04/04/2024
The Dermatologist

From the Issue

Jeff Yu, MD
Videos
04/29/2022
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Emma Guttman-Yassky, MD, PhD
Feature Story
10/10/2021
Peter Sonnenreich, Contributing Writer
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical...
10/10/2021
The Dermatologist
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
NEA Approved Features
05/17/2021
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most...
05/17/2021
The Dermatologist
Quiz: Pain in Atopic Dermatitis
NEA Approved Features
03/12/2021
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most...
03/12/2021
The Dermatologist
Get Eczema Wise During Eczema Awareness Month
Partner Approved
10/16/2020
Lauren Mateja, Managing Editor
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Dupilumab Treatment Provides Multidimensional Improvement of Signs, Symptoms, and Quality of Life in Children With Severe Atopic Dermatitis: A Pictorial Guide
Feature Story
08/13/2020
Brad Shumel, MD, Ana B. Rossi, MD, CMD
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by...
08/13/2020
The Dermatologist
Feature Story
08/05/2024
Have natural language processing and large language models matured enough to support implementation of artificial intelligence-assisted scribing in the right clinical setting?
Have natural language processing and large language models matured enough to support implementation of artificial intelligence-assisted scribing in the right clinical setting?
Have natural language processing...
08/05/2024
The Dermatologist
NEA Approved Features
05/03/2024
Jessica Garlewicz, Digital Managing Editor
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the connection between their mental health and their eczema symptoms, they may be more likely to seek support.
When patients are aware of the...
05/03/2024
The Dermatologist
Feature Story
03/06/2024
Ross Lane Pearlman, MD
Innovations like machine learning models will change everything. But not in the most obvious ways.
Innovations like machine learning models will change everything. But not in the most obvious ways.
Innovations like machine...
03/06/2024
The Dermatologist
Feature Story
12/05/2023

Nicole Natarelli, BA; Monica Khadka, BA, BS; Amanda Krenitsky, MD; and Ann Lin, DO, MS

Nicole Natarelli, BA; Monica Khadka, ...
Social media platforms provide novel opportunities for physicians and patients to share health information, but the accuracy of posts must be vetted to avoid misinformation.
Social media platforms provide novel opportunities for physicians and patients to share health information, but the accuracy of posts must be vetted to avoid misinformation.
Social media platforms provide...
12/05/2023
The Dermatologist
NEA Approved Features
12/05/2023
Riya Gandhi, MA, Associate Editor
New research reveals a web of associated conditions and financial and access burdens, paving the way for a more comprehensive approach to patient care.
New research reveals a web of associated conditions and financial and access burdens, paving the way for a more comprehensive approach to patient care.
New research reveals a web of...
12/05/2023
The Dermatologist
Feature Story
10/17/2023

Tracey C. Vlahovic, DPM, FFPM RCPS (Glasg)

Tracey C. Vlahovic, DPM, FFPM RCPS (G...
Familiarity with the key points and questions outlined in the proposed algorithm is the first step in optimizing outcomes for these patients.
Familiarity with the key points and questions outlined in the proposed algorithm is the first step in optimizing outcomes for these patients.
Familiarity with the key points...
10/17/2023
The Dermatologist
Feature Story
09/11/2023
Lauren Hollins, MD; Norhan Shamloul, MD; and Todd Cartee, MD
With data showing that patients with skin of color have higher morbidity and mortality from skin cancers despite lower incidence rates, it is time to reassess how our care is delivered and who is delivering that care.
With data showing that patients with skin of color have higher morbidity and mortality from skin cancers despite lower incidence rates, it is time to reassess how our care is delivered and who is delivering that care.
With data showing that patients...
09/11/2023
The Dermatologist
NEA Approved Features
09/11/2023
Jessica Garlewicz, Digital Managing Editor
Dr Peter Lio provides a brief on the current topicals used to treat atopic dermatitis in children.
Dr Peter Lio provides a brief on the current topicals used to treat atopic dermatitis in children.
Dr Peter Lio provides a brief on...
09/11/2023
The Dermatologist
NEA Approved Features
08/11/2023
Jessica Garlewicz, Digital Managing Editor
A recent study sheds light on this often overlooked aspect of the disease in pediatric patients.
A recent study sheds light on this often overlooked aspect of the disease in pediatric patients.
A recent study sheds light on...
08/11/2023
The Dermatologist
NEA Approved Features
06/12/2023
Lauren Hewett
New research from the National Eczema Association reveals that eczema patients and caregivers want to be involved in decision-making for their treatments.
New research from the National Eczema Association reveals that eczema patients and caregivers want to be involved in decision-making for their treatments.
New research from the National...
06/12/2023
The Dermatologist

Advertisement

Advertisement

Advertisement